Pages that link to "Q30438582"
Jump to navigation
Jump to search
The following pages link to Discovery and validation of urinary biomarkers for prostate cancer (Q30438582):
Displaying 50 items.
- Proteomics and peptidomics: moving toward precision medicine in urological malignancies (Q26749401) (← links)
- Urinary proteomics and metabolomics studies to monitor bladder health and urological diseases (Q26752864) (← links)
- Urinary collagen fragments are significantly altered in diabetes: a link to pathophysiology (Q28475613) (← links)
- Peptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkers (Q28477629) (← links)
- Seminal plasma as a source of prostate cancer peptide biomarker candidates for detection of indolent and advanced disease (Q28534235) (← links)
- CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics (Q30437141) (← links)
- Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments (Q30438814) (← links)
- Classical MALDI-MS versus CE-based ESI-MS proteomic profiling in urine for clinical applications (Q31148183) (← links)
- Adapting mass spectrometry-based platforms for clinical proteomics applications: The capillary electrophoresis coupled mass spectrometry paradigm (Q33436829) (← links)
- Biomarker analysis for prostate cancer diagnosis using LC-MS and CE-MS. (Q33451945) (← links)
- Urine Peptidomics for Clinical Biomarker Discovery (Q33698379) (← links)
- Urine collection and processing for protein biomarker discovery and quantification (Q33780855) (← links)
- Urinary proteomics as a novel tool for biomarker discovery in kidney diseases (Q33781011) (← links)
- Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy (Q33985444) (← links)
- Fibrinogen alpha chain precursor and apolipoprotein A-I in urine as biomarkers for noninvasive diagnosis of calcium oxalate nephrolithiasis: a proteomics study (Q34043307) (← links)
- Mass spectrometry-based proteomics in Chest Medicine, Gerontology, and Nephrology: subgroups omics for personalized medicine (Q34691573) (← links)
- Application of Proteomics to Cancer Early Detection (Q35053031) (← links)
- Current peptidomics: applications, purification, identification, quantification, and functional analysis (Q35212347) (← links)
- Advances in urinary protein biomarkers for urogenital and non-urogenital pathologies (Q35460015) (← links)
- State-of-the-art nanoplatform-integrated MALDI-MS impacting resolutions in urinary proteomics (Q35570959) (← links)
- Urinary Biomarkers for Prostate Cancer (Q35854622) (← links)
- Current state of the art for enhancing urine biomarker discovery (Q36032361) (← links)
- An individual urinary proteome analysis in normal human beings to define the minimal sample number to represent the normal urinary proteome (Q36531291) (← links)
- The present and future of prostate cancer urine biomarkers (Q37007392) (← links)
- Amyloid-β Precursor Protein Modulates the Sorting of Testican-1 and Contributes to Its Accumulation in Brain Tissue and Cerebrospinal Fluid from Patients with Alzheimer Disease (Q37241399) (← links)
- Optimization for peptide sample preparation for urine peptidomics (Q37621867) (← links)
- Urine biomarkers in prostate cancer (Q37672247) (← links)
- Urinary proteomics--a tool for biomarker discovery (Q37701845) (← links)
- CE-MS and related techniques as a valuable tool in tumor biomarkers research. (Q37720614) (← links)
- Capillary electrophoresis-mass spectrometry for the analysis of intact proteins 2007-2010. (Q37822373) (← links)
- CE‐MS in biomarker discovery, validation, and clinical application (Q37833587) (← links)
- Systematic antibody and antigen-based proteomic profiling with microarrays (Q37853185) (← links)
- Urinary proteomics in cardiovascular disease: Achievements, limits and hopes (Q37869464) (← links)
- Urine proteomics in kidney and urogenital diseases: Moving towards clinical applications (Q37876853) (← links)
- Clinical application of urinary proteomics/peptidomics (Q37945790) (← links)
- Developments in coupled solid‐phase extraction–capillary electrophoresis 2009–2011 (Q37962484) (← links)
- Proteomics in hypertension and other cardiovascular diseases (Q38020003) (← links)
- Toward the detection of prostate cancer in urine: a critical analysis. (Q38047103) (← links)
- Biomarkers for the diagnosis of new and recurrent prostate cancer (Q38052926) (← links)
- Proteomic studies of urinary biomarkers for prostate, bladder and kidney cancers (Q38084817) (← links)
- Novel approaches for the identification of biomarkers of aggressive prostate cancer (Q38117841) (← links)
- Clinical applications of capillary electrophoresis coupled to mass spectrometry in biomarker discovery: Focus on Bladder Cancer (Q38130892) (← links)
- Clinical proteomics in obstetrics and neonatology (Q38176934) (← links)
- Capillary zone electrophoresis on-line coupled to mass spectrometry: A perspective application for clinical proteomics (Q38340351) (← links)
- CE-MS-based proteomics in biomarker discovery and clinical application (Q38340358) (← links)
- Recent progress in urinary proteome analysis for prostate cancer diagnosis and management (Q38613772) (← links)
- Implementation of CE-MS-identified proteome-based biomarker panels in drug development and patient management (Q38906256) (← links)
- Urinary biomarkers for renal tract malformations. (Q38993548) (← links)
- Liquid biopsy: a step forward towards precision medicine in urologic malignancies (Q39243268) (← links)
- The diagnostic value of PCA3 gene-based analysis of urine sediments after digital rectal examination for prostate cancer in a Chinese population (Q39955966) (← links)